Tizona Therapeutics Stock

tizonatx.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $95.24MM

Tizona Therapeutics is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases.

Register To Buy and Sell Shares

For more details on financing and valuation for Tizona Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Tizona Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Tizona Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Scott Clarke
Chief Executive Officer & Board Member
Mark Smyth Ph.D
Advisor Board Member & Scientific Co-Founder
Christine O'Brien
Chief Operating Officer
Shelly Pinto
Controller & Vice President, Finance
Joyson Karakunnel MD
Chief Medical Officer & Senior Vice President
Courtney Beers Ph.D
Chief Scientific Officer
John Corbin Ph.D
Chief Technology Officer

Board Members

Daniel Spiegelman
Scott Clarke
Daniel Hicklin Ph.D
MPM Capital
Nina Kjellson
Canaan Partners
Shelley Chu Ph.D
Abingworth Management
Luke Evnin Ph.D
MPM Capital
Pablo Cagnoni MD
MPM Capital

Frequently Asked Questions About Tizona Therapeutics’ Stock

Can you buy Tizona Therapeutics’ stock?
Tizona Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Tizona Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Tizona Therapeutics’ stock?
Yes, you can sell stock of a private company like Tizona Therapeutics. Forge can help you sell your Tizona Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Tizona Therapeutics’ stock price?
Tizona Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Tizona Therapeutics’ private market stock price with Forge Data.
What is Tizona Therapeutics’ stock ticker symbol?
Tizona Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Xconomy: Tizona Lands $105M from AbbVie in Cancer Drug R&D Alliance
A cancer immunotherapy teed up for clinical trials by Tizona Therapeutics is now the centerpiece of a new partnership with AbbVie, which is paying the
Abingworth, Canaan lead $43 mln Series B for Tizona Therapeutics | PE Hub
Tizona Therapeutics Inc, a company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases, raised $43 million in Series B funding. Abingworth and Canaan Partners led the round with participation from Lightstone Ventures and existing Series A investors, including MPM Capital, Amgen Ventures, Astellas Venture Management and InterWest Partners.
Updated on: May 17, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.